Pharmacokinetic and clinical evaluation of SangCya and Neoral in stable, adult renal transplant patients: Preliminary results

被引：1
|
作者：
Gaston, RS [1 ]
Said, M [1 ]
Ward, M [1 ]
Jones, P [1 ]
机构：
[1] Univ Alabama, Birmingham, AL USA
来源：
TRANSPLANTATION | 1999年 / 67卷 / 07期
关键词：
D O I：
10.1097/00007890-199904150-00643
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
618
引用
收藏
页码：S161 / S161
页数：1
相关论文
共 50 条
  • [1] Pharmacokinetic and safety evaluation of SangCya vs Neoral or Sandimmune in stable renal transplant recipients
    Gaston, R
    Alloway, RR
    Gaber, AO
    Rossi, SJ
    Schroeder, TJ
    Irish, WD
    Canafax, DM
    First, MR
    [J]. TRANSPLANTATION PROCEEDINGS, 1999, 31 (1-2) : 326 - 327
  • [2] Pharmacokinetic comparison of two cyclosporine A formulations, SangCya (Sang-35) and Neoral, in stable adult liver transplant recipients
    Fisher, RA
    Pan, SH
    Rossi, SJ
    Schroeder, TJ
    Irish, WD
    Canafax, DM
    Lopez, RR
    [J]. TRANSPLANTATION PROCEEDINGS, 1999, 31 (1-2) : 394 - 395
  • [3] SangCya is bioequivalent to neoral in stable cardiac allograft patients
    Renlund, D
    Taylor, D
    Kfoury, A
    Campbell, B
    Eidson, M
    Walker, K
    Irish, W
    [J]. TRANSPLANTATION, 1999, 67 (07) : S25 - S25
  • [4] A pharmacokinetic conversion study of Abbott cyclosporine and Neoral® in stable renal transplant recipients
    Tomlanovich, S
    Pollak, R
    Roza, A
    Merion, R
    Scandling, J
    Greco, R
    Dubé, L
    Awni, W
    Nabulsi, A
    [J]. TRANSPLANTATION, 1999, 67 (07) : S163 - S163
  • [5] Sangcya® oral solution compared to Neoral® capsules in de novo adult renal transplant recipients:: Results of a south-eastern organ procurement foundation(SEOPF) clinical trial.
    McCune, T
    Light, J
    Adams, P
    Peters, T
    Mendez-Picon, G
    Zibari, G
    Pruitt, T
    Yium, J
    Ham, J
    Thompson, J
    King, A
    Tate-Jordon, M
    Irish, W
    Chan, G
    Thacker, L
    Blanton, J
    Armata, T
    [J]. TRANSPLANTATION, 2000, 69 (08) : S162 - S162
  • [6] Conversion to cyclosporine microemulsion (Neoral) in stable renal transplant patients: Results from a single center
    Cossu, M
    Satta, R
    Branca, GF
    Pala, PG
    Serra, G
    Satta, RP
    Sorba, G
    [J]. TRANSPLANTATION PROCEEDINGS, 1998, 30 (05) : 1762 - 1763
  • [7] Clinical evaluation of efficacy and safety of cyclosporine (Imusporin) in renal transplant patients with stable graft function maintained on neoral or bioral
    Jha, Mrigank S.
    Srivastava, Aneesh
    Dubey, Deepak
    Gupta, Amit
    Sharma, R. K.
    Kumar, Anant
    [J]. INDIAN JOURNAL OF UROLOGY, 2007, 23 (02) : 130 - 132
  • [8] Substitution of sandimmun neoral® with a generic cyclosporine a microemulsion formulation (sigmasporin microral®) in stable renal transplant patients:: Clinical evaluation results after 6 months
    Alwakeel, Jamal S.
    Dham, Ruwayda S.
    Shaker, Duraid S.
    [J]. NEPHROLOGY, 2008, 13 : A80 - A80
  • [9] NEORAL IN LIVER-TRANSPLANT PATIENTS - PHARMACOKINETIC STUDY AND CLINICAL IMPLICATIONS
    BELLI, LS
    SLIM, OA
    DECARLIS, L
    RONDINARA, GF
    ALBERTI, A
    ZOPPI, F
    BELLATI, G
    FESCE, E
    AIROLDI, A
    COLOMBO, D
    DIGREGORIO, M
    IDEO, G
    BELLI, L
    [J]. TRANSPLANTATION PROCEEDINGS, 1994, 26 (05) : 2981 - 2982
  • [10] Preliminary results of a randomised, controlled study investigating the withdrawal of neoral in stable renal transplant recipients receiving mycophenolate mofetil in addition to neoral and steroids.
    Abramowicz, D
    Manas, D
    Lao, M
    Vanrenterghem, Y
    del Castillo, D
    Barker, D
    [J]. TRANSPLANTATION, 1999, 67 (07) : S240 - S240
12345